Kadono, Mitsuki
Nakashima, Ayumu http://orcid.org/0000-0002-7838-1494
Ishiuchi, Naoki
Sasaki, Kensuke
Miura, Yoshie
Maeda, Satoshi
Fujita, Asuka
Sasaki, Ayano
Nagamatsu, Shogo
Masaki, Takao
Funding for this research was provided by:
Japan Agency for Medical Research and Development (21bk0104124h0001)
Article History
Received: 20 January 2023
Accepted: 30 October 2023
First Online: 22 November 2023
Declarations
:
: Collection of the adipose tissue was approved by the Medical Ethics Committee of Hiroshima Graduate School of Biomedical Science, and written informed consent was obtained from each patient. Title of the approved project; Development of repair therapy for tissue damage using adipose-derived mesenchymal stem cells. Approval number: E-1516. Date of approval: January 29, 2019. All animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Hiroshima University (Hiroshima, Japan). Title of the approved project: Adipose derived Mesenchymal stem cells suppress apoptosis and protect renal function from contrast induced nephropathy. Approval number: A22-12. Date of approval: April 18, 2021.
: Not applicable.
: The Department of Stem Cell Biology and Medicine, Graduate School of Biomedical & Health Sciences, Hiroshima University is a collaborative research laboratory funded by TWOCELLS Company, Limited. Drs. Maeda and Miura are researchers employed by TWOCELLS Company, Limited. Except for the abovementioned disclosures, all authors have declared that no conflict of interest exists.